18
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38707 |
MPC-0767
|
||
MPC-0767, a potent, selective, and orally active hsp90 inhibitor, is the L-alanine ester prodrug of MPC-3100, exhibiting enhanced chemical stability. | |||
T21600 |
MPC-3100
|
||
MPC-3100 是一种有口服生物活性的的合成第二代 Hsp90小分子抑制剂,具有良好的药代动力学特性和显著的抗肿瘤作用。 | |||
T13298 |
Verubulin hydrochloride
MPC-6827 hydrochloride,N-(4-甲氧基苯基)-N,2-二甲基-4-喹唑啉胺盐酸盐 |
Microtubule Associated | Cytoskeletal Signaling |
Verubulin hydrochloride (MPC-6827 hydrochloride) 是一种血脑屏障渗透性微管破坏剂,具有强效和广谱的细胞毒活性,在人 MX-1 乳腺癌和其他小鼠异种移植癌模型中具有有效的抗癌活性。 | |||
T17229 |
Verubulin
MPC 6827 |
Microtubule Associated | Cytoskeletal Signaling |
Verubulin is a microtubule-disrupting agent with potent and broad-spectrum in vitro and in vivo cytotoxic activities. | |||
T5376 |
Aranidipine
阿雷地平,MPC1304 |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Aranidipine (MPC1304) 是一种钙通道拮抗剂,具有强效和持久的抗高血压作用。 | |||
T5843 |
Tarenflurbil
MPC7869,(R)-Flurbiprofen,R-flurbiprofen,氟比洛芬,R-氟比洛芬 |
Retinoid Receptor; Autophagy | Autophagy; Metabolism |
Tarenflurbil ((R)-Flurbiprofen) 是 Flurbiprofen 的 R 型对映体,可抑制 [3H]9-cis-RA 结合到 RXRαLBD,IC50为 75 μM。它可研究阿尔兹海默症。 | |||
T1768 |
7ACC2
|
Mitochondrial Metabolism; Monocarboxylate transporter | Membrane transporter/Ion channel; Metabolism |
7ACC2 是单羧酸盐转运蛋白抑制剂,IC50为 11 nM。它还是线粒体丙酮酸转运的有效抑制剂,可抑制乳酸涌入,通过抑制乳酸通量来发挥抗癌作用。 | |||
T9235 |
GW604714X
2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]- |
Mitochondrial Metabolism | Metabolism |
GW604714X (2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]-) 是一种高度特异性的线粒体丙酮酸载体抑制剂,Ki<0.1 nM。它是一种线粒体呼吸抑制剂。它也能抑制质膜单羧酸转运体的 L-乳酸转运,但浓度比 MPC 的大 4 个数量级。 | |||
T2607 |
MSDC 0160
CAY10415,Mitoglitazone,MSDC0160,MSDC-0160 |
Others; IGF-1R; Mitochondrial Metabolism | Metabolism; Others; Tyrosine Kinase/Adaptors |
MSDC 0160 (CAY10415) 是一种线粒体丙酮酸载体(MPC) 的调节剂,也是调节噻唑烷二酮的线粒体靶标 (mTOT) 的胰岛素增敏剂。它是一种噻唑烷二酮 (TZD),具有抗糖尿病和神经保护活性作用。它具有用于阿尔茨海默氏病的潜力。 | |||
T39792 | AMPC | ||
AMPC, a powerful and efficient inhibitor of TFF3, demonstrates inhibitory effects on cell proliferation, survival, oncogenicity, and CSC-like behavior in TFF3-positive CMS4 CRC cells. It acts as a promising standalone anti-cancer agent and also enhances the effects of 5-FU when used in combination, making it a valuable tool for cancer research. | |||
T60419 | Cyclic HPMPC | ||
Cyclic HPMPC 是有效的抗病毒剂,可以增加感染致死性牛痘苗病毒 (IHD 株) 小鼠的动脉氧饱和度水平。用 Cyclic HPMPC 治疗可改善先天性豚鼠巨细胞病毒 (GPCMV) 感染的结果并减少豚鼠模型中的病毒复制。 | |||
T74285 |
EDMPC
|
||
EDMPC,一种阳离子脂质,有效递送DNA至肺组织,亦用于向啮齿动物叶内递送DNA。 | |||
T79693 | PIMPC | GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
PIMPC为具抗氧化及金属螯合性能之化合物,新型糖原合成酶激酶3(GSK-3)抑制剂,潜在抗阿尔茨海默病作用。 | |||
T71538 | AMPCP | ||
AMPCP is an Ecto-5'-nucleotidase (CD73) inhibitor. | |||
T24495 |
MPCI
|
||
MPCI is a selective melanocortin-4 receptor antagonist. | |||
T4441 |
UK-5099
UK 5099,PF-1005023,UK5099 |
Others; Mitochondrial Metabolism | Metabolism; Others |
UK-5099 (PF-1005023) 是一种有效的线粒体丙酮酸转运蛋白(MPC) 抑制剂, 抑制丙酮酸依赖性 O2消耗的 IC50值为50 nM。 | |||
T38715 |
MSDC-0602K
MSDC-0602K,Azemiglitazone potassium |
PPAR | DNA Damage/DNA Repair; Metabolism |
MSDC-0602K (Azemiglitazone potassium) (Azemiglitazone potassium) is a PPARγ-sparing thiazolidinedione (Ps-TZD) compound that binds to PPARγ with an IC50 of 18.25 μM. It also modulates the mitochondrial pyruvate carrier (MPC). This compound, MSDC-0602K, has potential applications in researching fatty liver conditions, including dysfunctional lipid metabolism, inflammation, and insulin resistance. MSDC-0602K acts as an insulin sensitizer, improving insulinemia and fatty liver disease in mice both ... | |||
T4639 |
Azemiglitazone
MSDC 0602 |
Mitochondrial Metabolism; mTOR | Metabolism; PI3K/Akt/mTOR signaling |
Azemiglitazone (MSDC 0602) 是一种 PPARγ 保留的噻唑烷二酮类药物 (TZD),与能够线粒体丙酮酸载体 (MPC) 相互作用并抑制其活性,降低 pparγ 介导的副作用的风险,有用于 2 型糖尿病研究的潜能。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5782 |
Bevirimat
YK FH312,MPC-4326,PA-457,贝韦立马 |
HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Bevirimat (PA-457) 是一种 HIV-1 成熟抑制剂,可在病毒体成熟过程中阻断 Gag 衣壳 (CA) 前体 CA-SPI 裂解为成熟的 CA 蛋白。 |